Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytes

Oncogene volume 20, pages 7430–7436 (2001)Cite this article

Abstract

Fibroblast growth factor binding protein (FGF-BP) is a secreted protein that binds FGF-1 and FGF-2 and is involved in mobilization and activation of FGFs from the extracellular matrix. FGF-BP overexpression as well as ribozyme-mediated reduction of endogenous FGF-BP revealed that FGF-BP can be rate-limiting for tumor growth and angiogenesis. Recent studies showed that FGF-BP expression is up-regulated during early phases of tumorigenesis, indicating that the role of FGF-BP in angiogenesis is a critical early step in the development and progression of tumors. Human papillomavirus type 16 (HPV 16) is highly associated with the development of anogenital cancers. Here we demonstrate that the stable expression of the E6 oncogene of HPV 16 leads to an activation of the FGF-BP promoter in primary human foreskin keratinocytes (one of the natural host cells of these viruses). This is associated with an increase in the steady state levels of FGF-BP mRNA and FGF-BP protein in cells stably expressing E6. Transient E6 expression revealed that the observed activation of the FGF-BP promoter by the viral oncogene is an early process which is independent from immortalization/transformation events in the cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aigner A, Butscheid M, Kunkel P, Krause E, Lamszus K, Wellstein A, Czubayko F . 2001 Int. J. Cancer 92: 510–517

  • Arbeit JM, Olson DC, Hanahan D . 1996 Oncogene 13: 1847–1857

  • Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1998 Nature 391: 597–601

  • Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1999 EMBO. J. 18: 2449–2458

  • Burgess WH, Maciag T . 1989 Annu. Rev. Biochem. 58: 575–606

  • Coussens LM, Hanahan D, Arbeit JM . 1996 Am. J. Pathol. 149: 1899–1917

  • Crook T, Tidy JA, Vousden KH . 1991 Cell 67: 547–556

  • Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem GJ, Wellstein A . 1997 Nat. Med. 3: 1137–1140

  • Czubayko F, Riegel AT, Wellstein A . 1994 J. Biol. Chem. 269: 21358–21363

  • Dahiya A, Gavin MR, Luo RX, Dean DC . 2000 Mol. Cell. Biol. 20: 6799–6805

  • Dalton S . 1992 EMBO. J. 11: 1797–1804

  • Davies R, Hicks R, Crook T, Morris J, Vousden K . 1993 J. Virol. 67: 2521–2528

  • de Villiers E-M . 1989 J. Virol. 63: 4898–4903

  • Demers WG, Halbert CL, Galloway DA . 1994 Virology 198: 169–174

  • Dyson N, Guida P, Münger K, Harlow E . 1992 J. Virol. 66: 6893–6902

  • Dyson N, Howley PM, Münger K, Harlow E . 1989 Science 243: 934–937

  • Etscheid BG, Foster SA, Galloway DA . 1994 Virology 205: 583–585

  • Folkman J, Klagsbrun M . 1987 Science 235: 442–447

  • Goodrich DW, Lee W-H . 1993 Biochim. Biophys. Acta 1155: 43–61

  • Hanahan D, Folkman J . 1996 Cell 86: 353–364

  • Harris VK, Coticchia CM, Kagan BL, Ahmad S, Wellstein A, Riegel AT . 2000a J. Biol. Chem. 275: 10802–10811

  • Harris VK, Coticchia CM, List HJ, Wellstein A, Riegel AT . 2000b J. Biol. Chem. 275: 39801

  • Harris VK, Kagan BL, Ray R, Coticchia CM, Liaudet-Coopman ED, Wellstein A, Tate Riegel A . 2001 Oncogene 20: 1730–1738

  • Harris VK, Liaudet-Coopman ED, Boyle BJ, Wellstein A, Riegel AT . 1998 J. Biol. Chem. 273: 19130–19139

  • Huibregtse JM, Scheffner M, Howley PM . 1991 EMBO. J. 10: 4129–4135

  • Huibregtse JM, Scheffner M, Howley PM . 1993 Mol. Cell. Biol. 13: 4918–4927

  • Imai Y, Matsushima Y, Sugimura T, Terada M . 1991 J. Virol. 65: 4966–4972

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JL . 1994 Science 266: 2011–2015

  • Kinoshita T, Shirasawa H, Shino Y, Moriya H, Desbarats L, Eilers M, Simizu B . 1997 Virology 232: 53–61

  • Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK . 1994 Mol. Cell. Biol. 14: 961–969

  • Klingelhutz AJ, Foster SA, McDougall JK . 1996 Nature 380: 79–81

  • Kurtz A, Wang HL, Darwiche N, Harris V, Wellstein A . 1997 Oncogene 14: 2671–2681

  • Lopez-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS . 2000 Oncogene 19: 4611–4620

  • Mansur CP, Androphy EJ . 1993 Biochim. Biophys. Acta 1155: 323–345

  • Mason IJ . 1994 Cell 78: 547–552

  • Miller AD, Rosman GJ . 1989 Biotechniques 7: 980–982 984–986 989–990

  • Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J, Clark S, Wang Z . 2001 N. Engl. J. Med. 344: 1125–1131

  • Mudryi M, Hiebert SW, Nevins JR . 1990 EMBO. J. 9: 2179–2184

  • Nair P, Gangadevi T, Jayaprakash PG, Nair MB, Nair MK, Pillai MR . 1999 Pathol. Res. Pract. 195: 163–169

  • Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ . 2000 J. Biol. Chem. 275: 6764–6769

  • Patel D, Huang SM, Baglia LA, McCance DJ . 1999 EMBO. J. 18: 5061–5072

  • Powers CJ, McLeskey SW, Wellstein A . 2000 Endocr. Relat. Cancer 7: 165–197

  • Ronco LV, Karpova AY, Vidal M, Howley PM . 1998 Genes. Dev. 12: 2061–272

  • Scheffner M, Takahashi T, Huibregtse JM, Minna JD, Howley PM . 1992 J. Virol. 66: 5100–5105

  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . 1990 Cell 63: 1129–1136

  • Shino Y, Shirasawa H, Kinoshita T, Simizu B . 1997 J. Virol. 71: 4310–4318

  • Stöppler H, Conrad Stöppler M, Johnson E, Simbulan-Rosenthal CM, Smulson ME, Iyer S, Rosenthal DS, Schlegel R . 1998 Oncogene 17: 1207–1214

  • Stöppler H, Conrad Stöppler M, Schlegel R . 1994 Intervirology 37: 168–179

  • Stöppler H, Hartmann D-P, Sherman L, Schlegel R . 1997 J. Biol. Chem. 272: 13332–13337

  • Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M . 1987 Proc. Natl. Acad. Sci. USA 84: 2292–2296

  • Wu DQ, Kan MK, Sato GH, Okamoto T, Sato JD . 1991 J. Biol. Chem. 266: 16778–16785

  • Zimmermann H, Degenkolbe R, Bernard HU, O'Connor MJ . 1999 J. Virol. 73: 6209–6219

  • zur Hausen H . 1991 Virology 184: 9–13

Download references

Acknowledgements

We thank Dr Richard Schlegel, Georgetown University, for primary human foreskin keratinocytes, and Dr Melissa Conrad Stöppler, Philipps University, for scientific support and critical reading of the manuscript.

Author information

Author notes

  1. Hubert Stöppler and Claudius Malerczyk: H Stöppler and C Malerczyk contributed equally to this work

Authors and Affiliations

  1. Department of Pharmacology, Philipps University, Marburg, Germany

    Hubert Stöppler, Claudius Malerczyk, Katrin Block, Achim Aigner & Frank Czubayko

Authors
  1. Hubert Stöppler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudius Malerczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katrin Block
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Achim Aigner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frank Czubayko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank Czubayko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stöppler, H., Malerczyk, C., Block, K. et al. The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytes. Oncogene 20, 7430–7436 (2001). https://doi.org/10.1038/sj.onc.1204957

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204957

Keywords

This article is cited by

Search

Advanced search

Quick links